Literature DB >> 20063387

Long-term deep brain stimulation for essential tremor: 12-year clinicopathologic follow-up.

Daniel J DiLorenzo1, Joseph Jankovic, Richard K Simpson, Hidehiro Takei, Suzanne Z Powell.   

Abstract

We describe the clinical course and postmortem pathological findings in a patient with essential tremor (ET) treated with deep brain stimulation (DBS) for 12 years. This 75 year old woman had a 13-year history of progressive ET prior to implantation of bilateral quadripolar DBS electrodes in the region of her ventral intermediate thalamic nuclei in 1996, producing immediate relief of arm tremor. Histopathological examination of the brain, performed 12 years after the initial implantation, demonstrated electrode catheter tracts rimmed by 20-25 micron fibrous sheaths, with multinucleated giant cells and reactive gliosis. Lymphocytic infiltration was seen by L26 immunoreactivity with CD3 (T cells) staining predominating over CD20 (B cells). Cerebellar axonal spheroids and Purkinje cell loss were found. The minimal foreign body reaction and gliosis around the electrodes 12 years after implantation supports the long-term safety of DBS. The case represents the longest reported follow-up with autopsy examination after DBS and confirmed histological changes associated with ET. (c) 2009 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20063387     DOI: 10.1002/mds.22935

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  10 in total

Review 1.  Deep brain stimulation: are astrocytes a key driver behind the scene?

Authors:  Albert J Fenoy; Laurent Goetz; Stéphan Chabardès; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2014-01-24       Impact factor: 5.243

2.  Targeting of the pedunculopontine nucleus by an MRI-guided approach: a cadaver study.

Authors:  Ludvic Zrinzo; Laurence V Zrinzo; Luke A Massey; John Thornton; Harold G Parkes; Mark White; Tarek A Yousry; Catherine Strand; Tamas Revesz; Patricia Limousin; Marwan I Hariz; Janice L Holton
Journal:  J Neural Transm (Vienna)       Date:  2011-04-06       Impact factor: 3.575

3.  Advanced research on deep brain stimulation in treating mental disorders.

Authors:  Dongxin Wang; Xuejun Liu; Bin Zhou; Weiping Kuang; Tiansheng Guo
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

4.  Binucleated and Multinucleated Neurons are Formed by Fusion.

Authors:  O S Sotnikov
Journal:  Bull Exp Biol Med       Date:  2021-09-20       Impact factor: 0.804

5.  Long-term Thalamic Deep Brain Stimulation for Essential Tremor: Clinical Outcome and Stimulation Parameters.

Authors:  Pedro M Rodríguez Cruz; Antonio Vargas; Carlos Fernández-Carballal; Jose Garbizu; Beatriz De La Casa-Fages; Francisco Grandas
Journal:  Mov Disord Clin Pract       Date:  2016-03-01

6.  Effects of bilateral subthalamic nucleus deep brain stimulation on motor symptoms in Parkinson's disease: a retrospective cohort study.

Authors:  Guo-Xiong Cheng; Shu-Bin Yin; Ying-Hao Yang; Yuan-Hu Hu; Chih-Yang Huang; Qian-Ming Yao; Wei-Jen Ting
Journal:  Neural Regen Res       Date:  2021-05       Impact factor: 5.135

Review 7.  Deep Brain Stimulation: Expanding Applications.

Authors:  Anand Tekriwal; Gordon Baltuch
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-10-15       Impact factor: 1.742

Review 8.  Neuromodulatory Treatments for Alcohol Use Disorder: A Review.

Authors:  Anne-Mary N Salib; Allen L Ho; Eric S Sussman; Arjun V Pendharkar; Casey H Halpern
Journal:  Brain Sci       Date:  2018-05-28

9.  Astroglial networks and implications for therapeutic neuromodulation of epilepsy.

Authors:  Mark R Witcher; Thomas L Ellis
Journal:  Front Comput Neurosci       Date:  2012-08-29       Impact factor: 2.380

10.  Subthalamic Deep Brain Stimulation Affects Plasma Corticosterone Concentration and Peripheral Immunity Changes in Rat Model of Parkinson's Disease.

Authors:  Beata Grembecka; Wojciech Glac; Magdalena Listowska; Grażyna Jerzemowska; Karolina Plucińska; Irena Majkutewicz; Piotr Badtke; Danuta Wrona
Journal:  J Neuroimmune Pharmacol       Date:  2020-07-09       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.